शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ALKEMNSEAlkem Laboratories Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Thu, 22 Jan, 2026 · 15:12 IST

Alkem Labs gets GST demand of about Rs 4.69 cr including penalty

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.0%Reaction day
₹5630.00
prior close
₹5750.00
announcement price
In-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+1.2%+0.8% vs market
Pharmaceuticals peers, median of 156sector+1.2%+0.8% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Midcap 150 and 0.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
+0.4
15m
+0.5
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.0+1.2+0.8+1.2+0.8
Next day
+2.1-0.5+2.6+0.0+2.1
2d
+2.2+0.0+2.2-0.7+2.9
3d
+1.6+1.6-0.0+0.2+1.4
4d
+1.5+1.7-0.3-0.3+1.8
5d
+1.0+1.8-0.7+0.1+1.0
1w
+1.2+3.6-2.4+2.4-1.3
15d
-4.1+3.6-7.7+2.7-6.8
1m
-2.5+3.6-6.2+1.6-4.1
2m
-8.3-7.9-0.4-8.4+0.1
3m
-1.4+5.1-6.5+3.5-4.9
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Laboratories received a GST order from the Additional Commissioner, Central GST, Goa, demanding about Rs 2.35 crore in tax plus an equal amount as penalty for FY 2019-20 to 2022-23. The order alleges excess claim of Input Tax Credit. The company disagrees with the demand and plans to file an appeal. Alkem says there is no material impact on its financials, operations, or other activities.

Likely market impact

Tax demand is small versus company size; management says no material financial impact. Appeal pending.